MXPA98004446A - An apparatus and method for dosing a sanead formulation - Google Patents

Abstract

An automatic dosing method and apparatus for transporting concentrated concentrated chemicals to the site of use and then dosing the concentrated chemicals in a storage container to create a final or intermediate composition. The automatic dosing apparatus includes a computer program that calculates the proper formulation and then binds it with a controller to make the proper chemical concentrates and the appropriate volumes of those concentrates dosed. A method for generating a desired formulation is also described and claims

Description

AN APPARATUS AND METHOD FOR DOSING A SANITATION FORMULATION Field of the Invention The invention relates, in general terms, to a method and apparatus for dosing sanitizing and cleansing formulas. More specifically, the invention relates to a method and apparatus for transporting concentrates of chemical products to a site of use, generating a formula, and dosing the formula at the site of use.

Background of the Invention In the typical manufacture of sanitizing compositions, the ingredients are mixed in large mixing containers, packaged in disposable plastic containers and shipped via sales distribution channels to the final consumer, often hundreds of kilometers away from the consumer. distance from the source installation. These products often settle for months within the distribution system before their delivery and application. Due to this passage of time, the chemicals that can be used within these compositions are limited to those that have shelf life stability. Therefore, many other mixtures and ingredients can not be used (for example, superior antimicrobial agents that have limited shelf life). Many previous methods include the transport of fluids for mixing and distribution at the point of use. Van Ormer, U.S. Patent Number: 5,154,314, discloses a chemical product dispenser in a vehicle that dispenses fluids at the site of use. Rakucewicz, U.S. Patent Number: 4,641,693 also discloses a dispensing apparatus that administers a plurality of syrups for use in soft drinks concurrently from a truck. Sollander et al., U.S. Patent Number: 4,732,181, discloses an apparatus for distributing a foamy camouflage material for application to the earth or for filling containers that cover a vehicle. The foam producing apparatus is attached to a vehicle for easy transportation or for the camouflage of that vehicle. A water-based foam forming liquid passes through a housing where air is blown via a fan and the liquid is expelled through a nozzle resulting in a foaming material. Dyes are added to obtain the pattern of. desired camouflage. Sollander et al use an automatic dye control element allowing a continuous adjustment of the color of the foam with respect to that of the surroundings. The color control element includes photometers. A signal is fed back from the photometers to a computer, which in response to the comparison of these colors, controls the supply of different coloring agents to the foaming liquid. U.S. Patent Number: 5,193,720 to Mayberry discloses a vehicle dosing apparatus for dosing coating compositions in two parts such as paints. The vehicle is a portable cart. The two or more coating compositions are distributed on the site of use separately on the cart and then mixed at the site of use. Computer control is provided for mixing operations and dosing including formulations and quantities tailored to the customer. The Patent of the United States of North America Number: 5,203,366 for Czeck et al. Describes an apparatus for dosing chemical concentrates at a point of use. The apparatus includes an axial manifold having a plurality of input ports extending radially toward the center of the manifold. The control valves are located at the inlet ports to control the supply of chemical concentrates in the manifold and the chemicals are directed into the manifold by the operation of a positive displacement pump. The chemical concentrates are mixed in a filling station. A microprocessor controller manages the operation of the dosing apparatus and receives information from a flow etro located downstream of the manifold. The apparatus can be used to form dilute aqueous chemical compositions, or mixtures of chemical concentrates without added water. However, these patents do not teach the transport of liquid compositions that can then be mixed at the point of use, especially liquids that may be incompatible when mixed, or have a short shelf life once mixed. There is a need in the art for a method and apparatus for transporting concentrated chemicals to a site of use separately, determining the composition required at that specific use site, mixing the concentrated chemicals to arrive at the composition, and administering the composition determined to the site of use.

SUMMARY OF THE INVENTION The present invention provides a robust method and apparatus for dosing a final composition at a point of use. The principles of the invention include transporting a plurality of concentrated chemical compositions to the point of use using a vehicle having a plurality of concentrate containers disposed therein, wherein each concentrate container stores one of the plurality of concentrated chemical compositions; determining a desired formulation of a composition, the desired formulation specifying the predetermined amounts of at least one of the concentrated chemical compositions and a carrier; and generating and administering the desired formulation to the point of use. It will be appreciated that that desired formulation may be a final composition or an intermediate composition. This invention also includes an apparatus mounted on a vehicle for dosing a final composition at a point of use, the apparatus including a plurality of concentrate containers mounted on a delivery vehicle, each concentrate container housing a concentrated chemical composition for use in the formulation of a final composition; at least one delivery mechanism coupled in fluid communication with the plurality of concentrate containers to selectively deliver a measured quantity of each concentrated chemical composition to a storage container at the point of use; and a controller configured to activate the delivery mechanism to deliver a desired formulation of the final composition having predetermined amounts of at least two of the concentrated chemical compositions. An application example of the invention is an apparatus for incorporating variant concentrations of ingredients comprising bovine mastitis prevention and control mechanisms into a carrier fluid. This invention lends itself to the preparation of a plurality of mastitis treatment mixtures, each being designed to meet the mastitis control needs of a target flock. The invention also includes a method for generating a desired formulation of a final composition that includes the steps of receiving data input designating a particular formulation, the receiver input data designating the desired amount of formulation to be dosed, producing commands for a controller that designates the quantity of each of the concentrated chemical compositions for dosing, and producing a command for the controller to begin the dosing operations. Although the invention will be described with respect to the preferred embodiment, it will be understood that the invention should not be taken as limited in any way by those configurations or components described herein. The various advantages and characteristics that characterize the invention are pointed out with particularity in the claims appended hereto and forming part of the present. However, for a better understanding of the invention, its advantages and objectives obtained through its use, reference should be made to the drawing forming an additional part hereof and to the descriptive material, in which a preferred embodiment for the invention.

BRIEF DESCRIPTION OF THE DRAWING Referring to the drawing, wherein like numerals represent like parts throughout the varied views: Figure 1 is a schematic diagram illustrating the functional components of an apparatus constructed in accordance with the principles of the present invention together with the exemplary concentrated chemicals. Figure 2 is a functional block diagram of the controller 46 used by block 47 of Figure 1. Figure 3 is a top view of the apparatus of the invention in a delivery vehicle. Figure 4A is a functional block diagram of computer equipment, the software interfaces, and the connection thereof with the controller block 46 of Figure 2. Figure 4B is a logic flow diagram illustrating the programming steps implemented by the controller block 46. Figure 5A illustrates the on-screen display of the user interface initially generated by the programming block of the operator interface 112 during the operation. Figure 5B illustrates the user interface screen generated by the operator interface program 112 after the level 1 (low level) pass code has been entered and accepted. Figure 5C illustrates the user interface screen generated by the operator interface program 112 after the pass code of level 2 (high level) has been entered and accepted. Figure 6 is a logic flow diagram illustrating the basic data flow through the operation of the operator interface programming block 112. Figure 7 is a logic flow diagram illustrating the operation of the interface programming block of the operator 112 when calculating the amounts of chemical concentrate and carrier (eg, water). Figure 8 is a logic flow diagram illustrating the programming steps of the operator interface programming block 112 during product formulation. Figures 9a and 9b is a logic flow diagram illustrating the interface between the operator interface programming block 112 and the controller 46 of the invention.

Detailed Description As noted above, the principles of the present invention apply to the transport of concentrated chemicals to the site of use. Once at the site of use, the composition of the product is determined, the composition of the product is generated and delivered to the site of use. Although the present invention will be described in connection with the exemplary application of blister sealants, it will be appreciated that such application is typical of only one of innumerable types of applications in which the principles of the present invention may be employed. In order to fully describe the present invention, an overview of the components of the system comprising the apparatus constructed in accordance with the principles of the present invention will first be presented. Second, the hardware environment of the computer will be described. Third, a description of the allocation and operation elements thereof is provided. Finally, an example of work of the device in operation will be presented according to an exemplary application in which the principles of the present invention will be employed. to. System components and general view Turning first to Figure 1, there is illustrated a schematic diagram of the dispensing apparatus of this invention. Three containers of concentrates 10, 12 and 14 containing chemical concentrates are shown. However, it will be appreciated that another number of containers may be provided as desired and / or required for the environment in which the dispensing apparatus is employed. Exemplary chemical concentrates carried by containers 10, 12 and 14 include iodine premix, glycerin premix and sorbitol premix, respectively. The containers 10, 12 and 14 are preferably constructed of a material that is resistant to transport the chemicals and that does not interact with the concentrates used in that environment. According to the above, various metals and plastics can be used in different environments. Similarly, the volumes of the chemical concentrates carried by the containers 10, 12 and 14 can vary as required by the environment, and each of the containers can be made in a different size. In the preferred embodiment used in connection with the exemplary application, containers 10, 12 and 14 are constructed of polyethylene and have a volume of zero to 11250 (0-11250) liters. Each of the three containers of concentrate 10, 12 and 14 is connected to a fluid transport element. In the preferred embodiment, the fluid transport element is comprised of three T-stroke pumps,. M-1, 16, 18 and 20 and hoses 22, 24 and 26, respectively. Pumps 16, 18 and 20 are pumps that direct air through a double diaphragm with a volume of seven (210 milliliters) per stroke. It will be appreciated, however, that pumps 16, 18 and 20 may include both time-based pumps and / or impulse type pumps. For example, the resolution of the pumps can be of 0.1 second the resolution for the pumps based on time and the ON and OFF times for the resolution of 0.1 second. The pumps 16, 18 and 20 convey the concentrate via the hoses 28, 30 and 32, respectively, to the solenoid valve filling nozzles 34, 36 and 38. The solenoid valve jets respond to the control signals ( example, the operation of the dispenser can be controlled by electrical signals). A control device 47 provides these signals via lines 35, 37 and 39, respectively. Lines 35, 37 and 39 can be, for example, electrical wires. The hoses 28, 30 and 32 can be stored in hose reels 40, 42 and 44, respectively. In the preferred embodiment, the controlling device 47 may be a controller of the type manufactured by the assignee of the present invention under the designation SABRÉ ™. That control device 47 includes an entrance board and a luminous display for the operation of the user and the programming adapted to the client. The device 47 also includes a plurality of input and output lines for a processor block 46 (best seen in Figure 2 and described below). The processor block is composed of a programmable processor chip of the microprocessor type. Referring now to Figures 1 and 2, the three pumps 16, 18 and 20 are controlled by the processor block 46. The controller 47 is connected to the three pumps 16, 18 and 20 by the pneumatic air lines 48, 50 and 52, with a plurality of solenoids 54 , 56 and 58 coupled between a pressure source 60 and pneumatic air lines 48, 50 and 52, respectively. During the operation, the processor 46 (in response to the commands of a computer program 110 operating in the computer 100; described below) activates a pump 16, 18 or 20 for a predetermined period of time to fluidly transfer the associated chemical concentrate from the concentrate container 10, 12 or 14 to the valve spout 34, 36 or 38 at the site of use (for example, storage container 64). The processor 46 generates signals to open the valve jets 34, 36 and 38 while the associated pumps 16, 18 and 20 operate. * The storage container 64 preferably includes a meter for indicating to an operator and / or user the amount of liquid in the storage container 64. One or more sensors 68 can also be placed in the container 64. A feedback path 70 connects the sensors 68 to the processor 46 to provide processing information. The sensors 68 can be pH sensors, ion sensors, temperature sensors, or conductivity sensors each of which is well known in the art. It will be appreciated that other sensors could also be used to provide information to the processor 46. The processor 46 uses the feedback signal from the sensors 68 to adjust its control of the pumps 16, 18 and 20 to ensure that the desired amounts of concentrates are dosed. chemical A carrier (such as water or other diluent) is dosed into the storage container 64 through the hose 71. The correct volume is dosed by one of two methods. First, the running computer program conforming to the operator interface block 112 (best seen in Figure 3 and described below) can instruct the operator to manually dose the appropriate volume of water. Alternatively, a valve 73 in the hose 71 can be controlled by the controller 47 via the line 76. In the latter mode, a flow sensor 69 can be operatively provided in the hose 71. The flow sensor 69 is connected to the processor 46 via a feedback signal path 74. A pump 78, preferably of the M-2 T-type, recirculates the mixed composition in storage container 64 via hose 80 to reduce any settling and to ensure complete mixing of the concentrated chemicals that are dosed into the storage container 64. It should be appreciated that any mixing apparatus such as, for example, a mixing pump tube can be used.

Preferably, the components comprising the invention are placed in a vehicle (such as a truck) in order to transport, determine and dose the final solution at the site of use. Figure 3 functionally illustrates the various components of the present invention placed in such a vehicle 81. The vehicle 81 is shown including wheels 83, 84, 86 and 88 and the structure 82. The components shown in Figure 3 as being placed and configured within the structure 82 they are operatively mounted in the structure 82 in order to be transportable / mobile. However, the exact arrangement of the components in Figure 3 does not mean that it is limiting. It will be appreciated that many arrangements are possible that result in the advantages of this invention. As noted above, the concentrates of the chemicals flow from the hoses 28, 30 and 32 and into the storage container 64 to mix and result in a final composition. Although the storage container 64 is not shown illustrated on the vehicle 81, it can also be mounted on the vehicle 81. b. Computer Hardware Environment Figure 1 also illustrates an exemplary computer hardware environment for the present invention. The present invention is preferably implemented using a laptop personal computer 100 (i.e., a personal computer that has a Pentium ™ chip or equivalent). However, it will be appreciated that a computer 100 may be another type of computer, including a special-purpose computer. It is envisaged that the computer 100 includes a monitor 102, a flexible disk drive 104 and / or a hard disk drive 105. Also in the preferred embodiment, input devices may be included, for example, a keyboard 106 and / or a device pointing (not shown). The computer 100 can also be connected to an output device such as the printer 116. The computer 100 operates under the control of an operating system 108 (e.g., the WINDOWS ™ operating system) which is depicted in Figure 1 by the screen display on the monitor 102. The present invention is preferably implemented using one or more computer programs 110, which are represented in Figure 1 by the "windows" displayed on the monitor 102, which operates under the control of the operating system 108. Generally, computer programs are tangibly incorporated into a readable medium on a computer, for example, one or more of the fixed and / or removable data storage devices 104. Under the control of operating system 108, the computer programs 110 can be loaded from data storage devices 104 into computer memory 100. Computer programs 110 There are instructions that, when read and executed by the computer 100, cause the computer 100 to perform the steps necessary to execute the steps or elements of the present invention. Also shown in Figure 1, the computer 100 is electrically connected to the controller 46 via a RS-232, 111 serial link. Those skilled in the art will recognize that the exemplary environment illustrated in Figure 1 is not intended to limit the present invention. In contrast, those skilled in the art will recognize that other alternative hardware environments can be used without departing from the scope of the present invention. c. Operations of the Mobile Assignment Controller (MAC) Figure 4 illustrates a functional block diagram of the Mobile Assignment Controller (MAC) of the invention. In the preferred embodiment, the Mobile Assignment Controller includes three functional elements. It will be appreciated, however, that those functional elements do not necessarily need to be separated. For example, the functionality can combine in hardware and / or software to reach different number of functional elements. The first element is the interface programming block of the Operator 112. The interface of the Operator 112 is a portion of the computer program 110 that guides the operator through all available management options. In the preferred embodiment, the Operator Interface 112 program is written in Visual Basic. It also provides access to install the information using a password protection method. The second element is the programming block of SABRÉ ™ Interface 114. This element is another 110 computer program. But this element is "invisible" to the operator and the person installing it. The SABERrM interface 114 communicates with the Inferred of the Operator 112 using the DDE protocol which is a standard communication protocol. DDE communications are achieved by using Visual Basic text boxes with assigned topical names. Each box contains a numerical value. Approximately half of the frames are used for communication from the operator interface 112 to the SABRÉ ™ interface 114. The remaining codes provide information back to the operator interface block 112. The following Table 1 describes the tables and their uses.

TABLE 1 The controller 47 communicates with the SABRÉ ™ Interface 114 via the 111 RS-232 serial link. The purpose of the SABRÉ ™ interface 114 is to receive commands from the operator interface 112 and, in response to this, send commands to the controller 47 and receive information from the controller 47 and pass that information back to the operator interface 112. The third element of the mobile allocation controller is the controller 47 described above. Figure 4B illustrates the logic programming steps of the actions of the controller 47 - as it functions as part of the mobile assignment controller. It will be appreciated that although the controller 47 is described herein as actively waiting or operating in various functional ways, the processor 46 is implementing programming steps based on various data inputs and outputs to achieve the desired functional results. First, when turning on the controller 47 it is in the idle mode as represented by the block 400. In the idle mode the outputs of the controller 47 are all turned off and the controller 47 is waiting for operator action. Block 402 represents controller 47 accepting communication keys from the SABRÉ interface 114 to enter the "load mode" (the communication keys are keys sent via the RS-232 communications port). The Load mode is a mode in which the controller 47 is waiting to accept the files loaded in ASCII text that contain the programming for the controller 47. The block 404 represents the controller 47 accepting a file loaded from the SABRÉ ™ interface. All controller control features 47 are available at load time. Block 406 represents controller 47 responding to an "output load mode" command from the SABRÉ ™ 114 interface by returning to idle mode. In block 408, controller 47 accepts communication keys to select and start cycle # 1. Cycle # 1 is a combination of pump on and off times that generates a total run time expressed in minutes and seconds. Switching to block 410, controller 47 begins to follow the information programmed for cycle # 1. For example, pumps 16, 18 and 20 are cycled for the appropriate time based on the logical information loaded during the "loading" process as represented in block 404. In block 412 controller 47 checks if a key is detected of "pause" and, if one is detected, turn off all outputs and wait. The control outputs are outputs controlled by programming in the controller 47 (for example, the pneumatic air lines 48, 50 and 52, control lines 35, 37 and 39 and the control line 76). In block 414, controller 47 checks if a "stop" communication key is detected and, if one is detected, exits the cycle, turning off all control outputs and returning to inactive mode. In block 416 controller 47 responds to any communication request for status information. For example, the operation interface 112 (via the interface SABRÉ ™ 114) can request information from the controller 47 about the progress of the cycle and the time or impulse counts of the pump. After block 416, controller 47 returns to block 410 to continue the cycle through blocks 410, 412, 414 and 416 until the cycle is completed at the time at which controller 47 returns to inactive mode. As part of the Mobile Allocation Controller, the hard disk drive 105 and / or a disk in the flexible disk drive 104 (or any other storage medium electrically coupled to the computer 100) contains three databases: a Database of clients, a database of formulas and a database of the history of the administration. These databases are preferably defined in the Microsoft Corporation Access ™ software database. The databases include information for the computer program 110. The Client Database stores the names of the clients as well as a list of the formulations assigned for each client. The Formulas Database contains the proportions of the concentrated chemicals for each formulation. The Administration History Database stores historical information about the amount and type of formulation delivered to each client. During the operation of the mobile allocation controller, all operations start from an initial screen on monitor 102. Figure 5A illustrates this initial screen. The numbered tables 504-514 represent virtual buttons that can be activated by the operator as is well known in the art. A sketch of the screen is presented to allow the operator to make formulations with a minimum amount of knowledge about the operation of a personal computer. In the preferred mode, the steps that the operator must follow appear on the screen as numbered buttons that must be followed in numerical sequence. It should be noted that the interface between the computer 100 and the user can be in any form, such as virtual buttons, a keyboard 106, a touch screen or any other method in the computer technique. As noted above, a "mouse" type input device may be included in addition (or in place of the keyboard). In accordance with the above, the use of virtual buttons throughout this specification does not mean limiting the invention. From the screen shown in Figure 5A an operator can follow two trajectories. The first trajectory is a trajectory of "Install OPERATIONS". This path would normally be used by a person who installs the functionality of the mobile allocation controller, and would generally be performed in an office or plant location. The "Install OPERATIONS" path is selected by the operator by activating the "Open" button 514 and entering a second level step code. The second path is the trajectory of "FIELD OPERATION". This last path would be used by the person who actually formulates the final products in the client's place (for example, the site of use). The "FIELD OPERATION" path is selected when the operator selects in order, buttons numbered 504-512. The first trajectory, trajectory Install OPERATIONS, generally implies the following steps. The operator selects the "Open" button 514. Next, the screen (shown in Figure 5B) appears on the monitor. In the preferred embodiment, the computer program 110 prompts the user to enter the level 1 password or a level 2 password. Based on the user's response, access is granted to level 1 or level 2. If the access to level 1, then the screen shown in Figure 5B appears on the monitor and the user is allowed to edit the list of clients based on customer data. The person established with access level 1 can also initiate the transfer of the administration history stored on the hard disk 105 to a floppy disk in the floppy disk drive 104. The data is stored on the floppy disk in a format that can be be read by a database or a spreadsheet program. The ability to transfer files from administration histories directly to database programs or spreadsheets allows automatic preparation of billing documents. If access is granted to level 2, then the screen shown in Figure 5C appears on the monitor and the person installing it can edit information describing the type of pumps 16, 18 and 20 that are being used, as well as the parameters of operation of pumps 16, 18 and 20. For example, the person installing could specify the volume of chemical concentrate that pumps 16, 18 and 20 pump by blow and, depending on the viscosity of the concentrate, designate the rate of appropriate pump blows. The higher the viscosity of the concentrate, the more time per stroke is required to pump the concentrate in and out of the pump cylinder. A person who installs with access level 2 can edit the finished product formulations in addition to being able to perform all level 1 activities. Those skilled in the art will appreciate that other passwords and access schemes can be used in connection with the operation of the mobile allocation controller. The password access described herein should not be considered as limited, and is presented as an example of a modality. The person who installs with access level 1 can activate button 522, labeled "Clients" in order to add new ones, edit or remove information about clients and select formulations of products from a list of approved formulas. The person who installs with access level 2 can activate the button 521 labeled "install", in order to add, edit or remove information about organizing the pumps of the chemical products. This pump installation information includes "on time" and "off time" for stroke pumps T. Pump installation information also includes volume factors in liters per stroke or liters per second. Also included in "install" are the pass codes for both low pass (level 1) and high pass (level 2). The person who installs can activate the 526 button, labeled "formulas" (level 2) in order to add new, edit or remove raw materials and their respective properties in units per 100 units. The person who installs can activate button 528, labeled "DDE" (level 2) in order to monitor DDE activity. The person installing can activate the 530 button, labeled "Close" in order to leave the "INSTALL OPERATIONS" and return to the screen shown in Figure 5A. The person installing can activate the button 532 labeled "Reports" in order to create dated reports on the screen, create disk transfer information (information transferred from the hard disk drive to the disk drive 104) and delete ranges of report. The person installing can activate button 534, labeled "Exit" in order to exit computer program 110. Buttons 536 and 538, labeled "Pause" and "Abandon" are not active in the INSTALL OPERATIONS. The activation of the button 540 labeled "About" results in a display on the monitor of information about the computer program 110. The second path that can be followed from the opening screen shown in Figure 5A on the monitor 102 it is the FIELD OPERATION trajectory. The FIELD OPERATION trajectory is the trajectory taken at the site of use (for example, when it is desired to dose the composition). Figure 6 illustrates a flow chart showing the steps executed by the operator interface 112 when the operator has chosen the FIELD OPERATION path. The block 600 represents the interface of the operator 112 which gives access to the customer database and which presents a list of clients to the operator on the monitor 102 in response to the activation of the button 504 by the operator. Block 602 represents the operator selecting a client from the list. Block 604 represents the interface of operator 112 (in response to the activity of button 506 by the operator) having access to the customer database, retrieving a list of formulations authorized by the chosen customer and presenting that formulary list to the operator . Block 606 represents the operator selecting a formulation from the list of formulations presented. Block 608 represents the interface of operator 112 having access to the formula database to obtain the proportions of concentrated chemicals. Block 609 represents the interface of operator 112, in response to activation of button 508 by the operator, prompting the operator to give information that includes the current amount of final composition in storage container 64 and the desired amount of final composition. From the information presented, the operator interface 112 calculates the amount of each concentrate of chemical product to be dosed. Block 610 represents receipt of a request by the operator (by activating button 510) to dose the designated formulation from concentrate containers 10, 12 and 14 into storage container 64. It will be appreciated that soft buttons are also provided in controller 47 to do for pauses or abort the formulation.

Block 612 represents the operator interface 112 by placing the results of the formulation, such as which formulation was dosed and how much was dosed, into the database of the administration history. You can access the information in the administration history database to print reports and invoices. Block 614 represents the operator requesting a transfer of the administration history that is contained in the administration history database to a diskette or other tangible means for transfer to an inventory and billing system. The request of the operator represented by block 614 is made by activating button 512. The operator interface 112 may also prompt the operator to prepare a printed administration report for the customer. Figure 7 illustrates the subroutine of the operator interface 112 that performs the functional programming steps represented by block 609 in Figure 6. Specifically, these steps illustrated in Figure 7 comprise the calculation of amounts of concentrated chemicals and water to dose. Block 700 represents the operator designating a desire to enter quantities by activating button 508 Enter Quantities. "Block 702 represents the operator interface 112 prompting the operator to enter the current reading from the meter into storage container 64. This reading represents the amount of formulation already present in the storage container 64 prior to the current dosing action .. The block 704 represents the interface of the operator 112 prompting the operator to enter the capacity of the storage container 64. The block 706 represents the interface of the operator 112 calculating the quantity administered of the formulated product by subtracting the initial level of the final composition in storage container 64 (entered by the operator in response to the prompting represented by block 702) from the capacity of storage container 64. The amount administered is the amount of product formulated (the sum of concentrated chemicals and water) that must be added to the storage container 64 to fill it to capacity. Block 708 represents the interface of operator 112 by calculating the amount of each chemical concentrate that is required to formulate the quantity of formulated product administered. Block 710 represents the operator interface 112 by adding the total amount of chemical products to be added to the storage container 64. Block 712 represents the operator 112 interface by subtracting the total chemical amount, (determined by the interface of the operator 112 in block 710) of the quantity administered (calculated by the program in block 706), whereby the amount of water to be added to storage container 64 is calculated. Block 714 represents the operator interface 112 calculating the "meter reading after adding water", which is the point on the meter of the storage container 64 to which water must be added. The "reading of the meter after adding water" is calculated by adding the amount of water calculated in block 712 to the reading of the current meter entered by the operator in response to the prompting represented by block 702. Block 716 represents the interface of the operator 112 prompting the operator to add water to the tank until it reaches the "meter read after adding water" level. Figure 8 illustrates the functional programming steps included to formulate the product to be dosed. The functions represented by block 610 of Figure 6 are performed by the subroutine shown in Figure 8. First in block 800, the operator that designates a desire to formulate a specific product is represented by activating the "Formulate Product" button 510. Block 802 represents the operator interface 112 by loading the DDE frames with seconds or desired ON-pulse pulse counts of chemical products as previously calculated. The second pumping ON refers to the amount of time that a particular pump must be pumping in order to dose the desired amount of chemical concentrate connected to that particular pump. The pulse count refers to the number of strokes that a particular pump must pass in order to pump the desired amount of chemical concentrate connected to a particular pump. The relationship between impulse counts and volume can be determined by the volume of the pump cylinder. Block 804 represents the operator interface 112 verifying whether the SABRÉ ™ 114 interface is responding to commands by setting the command DDE send to reset (-1) and obtaining a response from the SABRÉ ™ interface 114. If there is no response from the interphase SABRÉ ™ 114, then the operator interface 112 informs the operator of an error as presented by block 813. If the SABRÉ ™ interface 114 responds, then, as represented in block 806, the SABRÉ ™ interface 114 loads controller 46 with a new text file. The text file contains all the information that is in the DDE tables such as the amount of water, and the amount of each chemical concentrate (expressed either as pulse counts or pumping ON time) that must be dosed. If there is an error loading the text file in the controller 47 then an error message is displayed on the monitor 102 as represented by block 809. If the text file is loaded in the controller 46 without error, then the interface of operator 112 instructs controller 47 to begin to formulate, as represented by block 808. If there is an error in giving the instruction to the controller to begin to formulate, then the operator interface 112 places an error message on the controller. monitor 102 as represented by block 809. Block 808 also represents the interface of operator 112 by observing the response values coming back from controller 47 to monitor the completion of dosing operations. When the dosing operations are finished, then the operator interface 112 resets the controller 47 as represented by the block 810, thereby eliminating the information in the text file from the memory of the controller 46. Because the controller 47 reprogramming in each formulation means that the number of different formulations is limited only by the capacity of the database of the support computer 100. The exact limit is determined by the space on the hard disk 105 but can easily be in the thousands of formulations. Moreover, in the event that a controller 47 fails, a new controller with unknown structure programming (including a new factory controller 47) can be put in place and will operate without any extra action from the operator. If there is an error resetting the controller 47, then the operator interface 112 informs the user of the error as represented by block 811. Block 812 represents the operator interface 112 recording the administration in the history database of the operator. the administration. Figure 9 illustrates the functional programming steps performed in the operations of the operator interface 112 and the SABRÉ ™ interface 114. These programming steps perform the subroutine that is generally represented by blocks 806, 808, 809, 810 and 811 of Figure-8. Block 900 represents that this is a subjection of the "interface command" designated by blocks 806, 808, 809, 810 and 811 of Figure 8. The description that follows is a generic description that applies to any DDE command. Block 902 represents the operator interface 112 by placing a command value in the DDE command send box. For example, a command value "-i" in the DDE command send box represents a command from the operator interface 112 to the SABRÉ ™ interface 114 to reset the controller 46. The standard DDE communication protocol is used. Block 904 represents the interface of operator 112 by verifying the DDE command response box for the expected response. If the expected response is not received, then the next step is shown in block 912 which will be briefly described. If the expected response is received, then the operator interface 112 sets the subactivity as complete, as represented by block 906, and then goes to block 908. Block 908 represents the operator interface 112 determining, based on the content of the DDE tables, if the controller 47 is operatively preparing a formulation. If the controller 47 is operatively preparing a formulated, then the operator interface 112 stores the final and actual chemical quantities reported by the interface in the DDE tables, as represented by block 910. If controller 47 is not operationally preparing a formula in block 908 (or if block 910 is completed), then the next step is represented by block 912. Block 912 represents the interface of operator 112 by checking the response box of the DDE command to find an error response (-1). If there is an error response, then the operator interface continues to block 934. If the activity is not complete and no error has occurred, then the operations revert back to the actions represented by block 904. If a error, then the operations return to the call function (represented by blocks 806, 808 or 810) as represented by block 914. The operator interface 112 checks to see if the process is currently in pause mode, as shown in FIG. represented by block 916. If the process is not in pause mode, then block 918 represents the interface of operator 112 by checking to determine whether the time period "time terminated" was exceeded. If the "time-out" period was exceeded then the operator 112 interface continues to block 934. If the activity is not complete and no error occurs, then the operations return to the actions represented by block 904. If presented an error, then the operations return to the call function (represented by the blocks 806, 808 or 810), as represented by the block 920. Next, the operator interface 112 checks to determine if the controller 46 is preparing a formulated, as represented by block 922. If controller 46 is not preparing a formulation, then the operator interface 112 determines whether the "Abandon" button of monitor 102 has been activated, as represented by block 924. If the button "Abandon" has been pressed, then block 932 represents the interface command that is reported again for the formulated product (the formulated product represented by Figure 8), which is has requested a leave (Abortion). If an "Abandon" button has not been activated then block 926 represents the interface of operator 112 determining whether the "Pause" button has been pressed. If the "Pause" button has been activated, then the operator interface 112 sets the DDE send command box to "3" (Pause), as represented by block 930. If the "Pause" button has not been activated , then block 928 represents the operator 112 interface using actual chemical usage amounts reported in the DDE tables to calculate the percentage of concentrated chemical that has been pumped for each pump, compared to the total amount of that chemical particular concentrate that is going to be dosed. Block 928 also represents the interface of operator 112 exhibiting the smallest percentage complete, whatever the pump might be, as the percentage of formulation is completed. Block 934 represents the interface of operator 112 determining whether the activity required in block 902 is complete and if an error has occurred. If the activity has not been completed and there are no errors, then the operation returns to block 904. If the activity is complete or if there is an error, then the operation goes back to the call function, that is, as represented by one of blocks 806, 808 or 810 in Figure 8. d. Applications An exemplary application for the dosage system of the invention is in the treatment of bovine mastitis. The compositions of this invention include typical mastitis control and prevention treatments often described as "tummy sealers," although of course other methods of aseptic topical application could be used., for example spraying or spreading or foam on the tits. When employed as a tits sealer, which is a particularly effective application practice, the tits of the animal are immersed in a container or receptacle containing a composition of the present invention. Preferably one half to three quarts of the distal end of the teat has been coated with the treatment. The compositions of the invention preferably have sufficiently low viscosity to allow easy application to the teat. However, these compositions are preferably not so thin that they run off completely from the end of the teat. These tits sealers should gently coat and form an effective continuous layer on the skin of the teat. It is desirable that the compositions flow downward slightly after application to form a thicker layer or "plug" through the orifice of the teat channel. By doing so, the composition provides a more effective prophylactic barrier against bacteria entering the teat canal. Sealing tits using a well-balanced formulation performs three essential functions. The sealing displaces the final drops of milk that adhere at the end of the teat which, if left unattended, become an excellent medium for infectious organisms. The seal kills most of the organisms present on the surface of the skin of the teat and inhibits the transport of pathogenic organisms in the teat canal. The sealing also protects the skin of the teat from irritation caused by exposure to adverse environmental factors, helps to heal minor skin damage and lesions of the teats, and helps to heal the teat and the udder globally. The batch sealants dosed according to the invention can generally comprise a carrier, an antimicrobial agent or mixture, one or a mixture of rheological modifiers, one or a mixture of emollients, a regulatory system, one or a mixture of surfactants, a chromophore or colorant, and other adjuvants or additives. Preferred compositions of this invention comprise ingredients that are generally considered safe, food additives or otherwise of food grade and are not in themselves or in mixture incompatible with milk or milk products. In the same way, the ingredients should be selected for any given composition that are cooperative in their combined effects if incorporated for their antimicrobial efficacy, physical integrity of the formulation or to facilitate the healing or health of the theta. 1. CARRIER Generally, the composition comprises a carrier which functions to dilute the active ingredients and facilitates application to the intended surface. The carrier is generally an aqueous or organic liquid such as water, an oil, a surfactant, an alcohol, an ester, an ether, or an organic or aqueous mixture of any of these. Water is preferred as a carrier or diluent in compositions of this invention for its universal availability and unquestionable economic advantages over other liquid diluents. Someone with ordinary experience in the field will realize the fact that the pH of the water can vary with constituents solubilized as hardness; however, water treatment or a well-designed regulator system can compensate for these water source variations and therefore neutralize any potential physical, chemical or antimicrobial interference to the end-use composition. 2. ANTIMICROBI AGENT Numerous inorganic and organic antimicrobial agents can be used in blister sealant compositions that include (but are not limited to) chlorine and bromine releasing compounds (eg hypochlorites and alkaline and alkaline earth hypobromites, isocyanurates, chlorinated derivatives of hydantoin, sulfamide, amine, etc.), complexes that release iodine or surfactants or polymers such as polyvinyl pyrrolidone (called iodophores), quaternary ammonium compounds, chlorhexidine salts, peroxy and peroxy acid compounds, protonised short chain carboxylic acids (eg, R = C7-C11, R-COOH), acidified anionic surfactants and chlorine dioxide. Of these topically applied antimicrobial agents that have been investigated for the control of bovine mastitis, iodophors, acidified anionic surfactants, and chlorhexidine salts currently appear to have gained widespread acceptance among dairy managers, are generally considered safe to use , show efficacy against microorganisms that cause mastitis; and, they are preferred in compositions of the present invention. 3. MODIFICATION OF RHEOLOGIA The composition of the invention may also contain one or more rheology modifiers, to increase the viscosity, or to thicken and cause the aqueous treatment to stick to the surface of the teat. Bonding allows the composition to remain in contact with transient and resident bacteria for longer periods of time, promoting microbiological efficacy and resisting wastage due to excessive dripping. The rheology modifier may be a film former or act cooperatively with a film forming agent to form a barrier that provides additional protection. Water-soluble or water-dispersible rheology modifiers that are useful can be classified as inorganic or organic. The organic thickeners can be further divided into natural and synthetic polymers with the latter still further subdivided into natural synthetic and synthetic oil based ones. Inorganic thickeners are usually compounds such as colloidal aluminum magnesium silicate (Veegum ™), colloidal clays (bentonites), or silicas (Cab-0-sils ™) which have been vaporized or precipitated to create particles with larger surface to size ratios. The natural hydrogel thickeners used are mainly exudates derived from plants. For example, gums of tragacanth, carayá, and acacia; and extracts such as caragena, locust bean gum, guar gum and pectin; or pure culture fermentation products such as xanthan gum are useful in the invention. Chemically, all these materials are salts of complex acid polysaccharides. The natural synthetic based thickeners which have application are the cellulose derivatives wherein the free hydroxyl groups in the linear glucose-anhydride polymers have been either etherified or esterified to give a family of substances which dissolve in water and give viscous solutions. This group of materials includes alkyl and hydroxyalkyl celluloses, specifically methyl cellulose, hydroxyethylmethacillin cellulose, hydroxypropylmethyl cellulose, hydroxybutylmethyl cellulose, hydroxyethyl cellulose, ethylhydroxyethyl cellulose, hydroxypropyl cellulose, and carboxymethyl cellulose. Water-soluble polymers based on synthetic petroleum are prepared by the direct polymerization of suitable monomers of which polyvinyl pyrrolidone, polyvinyl methyl ether, polyacrylic acid and polymethacrylic acid, polyacrylic amide, polyethylene oxide, and polyethylene oxide are representative. imine of polyethylene. Preferred aqueous thickeners that are most useful in this invention are those that are extremely pseudoplastic (non-Newtonian, fast-relaxing), tend not to develop a rigid three-dimensional structure from interpolymer interactions, have a low or negligible viscoelastic character and they have a high gel resistance. These rheological properties are manifested in a tipping sealant composition that has a smooth flow appearance, is easy to pour and apply over the teat, coats uniformly without forming sticky currents as the applicator is removed and remains firmly in place without falling meaningful Examples of preferred rheology modifiers are xanthan gum and hydroxyalkyl celluloses. Frequently, no rheology modifier is added to compositions of this invention as a separate ingredient because sufficient viscosity is imparted to the mixture by other constituents. For example, with mastitis control treatments employing iodine as the antimicrobial, sufficient viscosity can be imparted to the composition by the surfactant or the iodophor compound. This is a well-known phenomenon of colloidal and surface chemistry caused by micellar structures which are aggregates of tensoactives organized in three dimensions formed within the aqueous carrier. Another example are compositions containing high levels of emollients such as glycerin or sorbitol. These polyols desiccate the composition by associating hydrogen bonds with water molecules of the carrier which has the effect of increasing the viscosity. Generally, the concentration of thickener used in the present invention will be dictated by the final composition and by the application method on the teat. Spraying or fogging requires a lower composition viscosity for easy and effective treatment application than sealing. The film barrier sealers typically require a higher apparent viscosity needed to form thick coatings on the teats which will ensure an improved prophylactic effect. 4. EMOLLIENT The blister sealant compositions of the present invention generally also comprise an emollient and / or humectant for lubricating, conditioning and generally reducing and promoting the healing of irritation on the surface of the application teat which could result either from the antimicrobial agent, of the mechanical action of the milking machine or of the environmental conditions such as wind chill, dehydration, abrasion and sunburn. Any skin conditioning agent, soluble in water or dispersible in water, can be used in the present invention. Compositions such as polyhydric alcohols are useful in the invention including glycerin, sorbitol, mannitol, and propylene glycol and their homopolymers; fatty acid esters or simple monohydric alcohols including isopropyl palmitate or isopropyl myristate and similar esters; polyol esters of fatty acids; and, ethoxylated lanolins, vegetable oils, and derivatives of similar natural sources such as Aloe. Preferred emollients to be used in the invention include glycerin, sorbitol and propylene glycol. 5. REGULATOR SYSTEM The classical definition of a regulated solution is one that contains both a weak acid and its weak conjugate base, whose pH changes only slightly with the addition of acid or alkali. The weak acid becomes regulator when alkali is added, and the weak base becomes regulator when acid is added. Maintaining the pH of the compositions described in the present invention is necessary to minimize undesirable chemical changes that may inhibit the microbiological efficacy of the antimicrobial agent or cause a toxic or irritant effect on the teat. Any organic or inorganic material or mixture of materials having the desired effect of maintaining the pH of the composition within prescribed ranges can be used as the regulatory agent or regulatory system of the present invention. Of primary importance are the changes in pH caused by the chemicals that are naturally introduced to the composition by the water used as diluent and carrier; and, the pH deviation that sometimes accompanies the chemical equilibrium established within the compositions as the ingredients change or the concentrations vary. In practice, the pH of the bovine mastitis control treatments can vary from as low as about pH 2.0 to a maximum of about 11.0 depending mainly on the choice of antimicrobial agent that is being incorporated into the composition because the optimum efficacy is normally it occurs within a specific, narrow range of pH. Therefore the agent or regulatory system is chosen in accordance with the foregoing. If an iodophor is the antimicrobial agent, the pH range is typically from about 2.5 to 5.0 - the lower value being a limit to avoid excessive irritation of the teat surface. A typical and preferred regulator system would be citric acid and its alkali metal salt. However, any organic food acidulant and the corresponding conjugated weak base could be used. 6. TENSFACE The surfactant or surfactant mixture of the present invention can be selected from surface active agents, compatible, water soluble or water dispersible, nonionic, or anionic; or mixtures of each of both types. Nonionic and anionic surfactants offer diverse and comprehensive commercial selection, low price; and most importantly, excellent significant surface wetting-detersive effect. The surface active agents or "wetting agents" function to increase the penetrating activity of the invention on the tissue surface at the risk of mastitis caused by pathogens. The nonionic surfactants useful in the invention are generally characterized by the presence of an organic hydrophobic group and an organic hydrophilic group and are typically produced by the condensation of an organic aliphatic alkyl aromatic, or polyoxyalkylene hydrophobic compound with a hydrophilic alkaline oxide fraction the which in common practice is ethylene oxide or a product of the polyhydration thereof, polyethylene glycol. Virtually any hydrophobic compound having a hydroxyl, carboxyl, amino or amido group with a reactive hydrogen atom can be condensed with ethylene oxide, or its polyhydration adducts, or mixtures thereof with alkoxylenes such as propylene oxide to form an active agent in the surface, not ionic. The length of the hydrophilic polyoxyalkylene fraction that is condensed with any hydrophobic compound can be easily adjusted to produce a water-dispersible or water-soluble compound having a desired degree of balance between hydrophilic and hydrophobic properties. The nonionic surfactants useful in the present invention include: 1. Block polyoxypropylene-polyoxyethylene polymer compounds based on propylene glycol, ethylene glycol, glycerol, trimethylolpropane, and ethylenic diamine as the initiating reactive hydrogen compound. Examples of polymeric compounds made from an initiator propoxylation and ethoxylation sequence are commercially available under the tradename Pluronic® manufactured by BASF Corp. Pluronic® compounds are bifunctional compounds (two reactive hydrogens) formed by the condensation of ethylene oxide with a hydrophobic base formed by the addition of propylene oxide to two hydroxyl groups of propylene glycol. This hydrophobic portion of the molecule weighs from about 1,000 to about 4,000. The ethylene oxide is then added to sandwich this hydrophobe between hydrophilic groups, controlled by length to constitute from about 10 weight percent to about 80 weight percent of the final molecule. Tetronic® compounds are tetrafunctional block copolymers derived from the sequential addition of propylene oxide and ethylene oxide to ethylenic diamine. The molecular weight of the propylene oxide hydrotype ranges from about 500 to about 7,000; and the hydrophilic ethylene oxide is added to constitute from about 10 weight percent to about 80 weight percent of the molecule. 2. The products of the compensation of one mole of alkyl phenol wherein the alkyl constituent contains from about 8 to 18 carbon atoms with from about 3 to about 50 moles of ethylene oxide. The alkyl group may, for example, be represented by diisobutylene, di-amyl, polymerized propylene, isoctyl, nonyl, and di-nonyl. Examples of commercial compounds of these chemicals are commercially available under the trade name Igepal® manufactured by Rhone-Poulenc and Triton® manufactured by Union Carbide. 3. The products of the condensation of one mole of straight or branched chain saturated or unsaturated alcohol having from about 6 to about 24 carbon atoms with from about 3 to about 50 moles of ethylene oxide. The alcohol fraction may consist of mixtures of alcohols in the carbon range delineated above or may consist of an alcohol having a specific number of carbon atoms within this range. Examples of similar commercial surfactants are available under the trademark Noedol® manufactured by Shell Chemical Co. and Alfonic® manufactured by Vista Chemical Co. 4. Products of the condensation of one mole of straight or branched chain saturated or unsaturated carboxylic acid having from about 8 to about 18 carbon atoms with from about 6 to about 50 moles of ethylene oxide. The acid fraction may consist of mixtures of acids in the range of carbon atoms delineated above or may consist of an acid having a specific number of carbon atoms within the range. Examples of commercial compounds of this chemical are commercially available under the tradename Nopalcol® manufactured by Henkel Corporation and Lipopeg® manufactured by Lipo Chemicals, Inc. In addition to the ethoxylated carboxylic acids, the polyethylene glycol esters, other esters of Alkanoic acids formed by the reaction with glycerides, glycerin and polyhydric alcohols (saccharides or sorbitan / sorbitol) have application in this invention. All these ester fractions have one or more reactive hydrogen sites in their molecule that can undergo another acylation or addition of ethylene oxide (alkoxide) to control the hydrophilicity of these substances. 5. Compounds of (1) that are modified, essentially inverted, by adding ethylene oxide to ethylene glycol to provide a hydrophilic of designated molecular weight; and then add propylene oxide to obtain hydrophobic blocks at the (ends) outside the molecule. The hydrophobic portion of the molecule weighs from about 1,000 to about 3,100 with the central hydrophilic comprising 10 weight percent to about 80 weight percent of the final molecule. These inverted Pluronice® are manufactured by BASF Corporation under the tradename of surfactants Pluronic®. In the same way Tetronic® surfactants are produced by BASF Corporation by the sequential addition of ethylene oxide and propylene oxide to ethylenic diamine. The hydrophobic portion of the molecule weighs from about 2,100 to about 6,700 with the central hydrophilic comprising ib percent by weight to 80 percent by weight of the final molecule. 6. Tertiary amino oxides corresponding to the general formula: R ^ OR4) ,. N (R2) (R3) -? 0 Where the arrow is a conventional representation of a semipolar link; and R1, R2, and R3 can be aliphatic, aromatic, heterocyclic, alicyclic, or combinations thereof. Generally, for amino oxides of detergent interest, R is an alkyl radical of from about 8 to about 24 carbon atoms.; R2 and R are selected from the group consisting of alkyl or hydroxyalkyl of 1 to 3 carbon atoms and mixtures thereof; R is an alkaline or hydroxyalkylene group containing from 2 to 3 carbon atoms; and n ranges from 0 to about 20. Useful water-soluble amine oxide surfactants are selected from the alkyl di (lower alkyl) amine oxides. The most preferred nonionic surfactants for use in compositions practiced in the present invention include compounds of groups (1), (2) and (3). Also useful in the present invention are surface active substances that are categorized as anionic because the charge in the hydrophobe is negative; or surfactants in which the hydrophobic section of the molecule carries no charge unless the pH rises to neutrality or above (eg, carboxylic acids). The carboxylate, sulfonate, and phosphate are the solubilizing groups (hydrophilic) polar found in anionic surfactants. Of the cations (counts) associated with these polar groups, sodium, lithium and potassium impart solubility in water. Examples of suitable water-soluble anionic, synthetic compounds are the alkali metals (such as sodium, lithium and potassium) salts of alkyl mononuclear aromatic sulphonates such as alkylbenzene sulfonates containing from about 5 to about 18 carbon atoms in the alkyl group in a straight or branched chain, for example the salts of alkylbenzene sulphonates or sulfonates of alkyltoluene, xylene, cumene and phenol; alkylnaphthalene sulfonate and alkoxylated derivatives. Other anionic detergents are the olefin sulfonates, which include long chain alkene sulfonates, long chain hydroxyalkane sulfonates or mixtures of alkene sulphonates and hidoxyalkene sulfonates. Also included are alkyl sulphates, alkylpoly (ethyleneoxy) ether sulphates and aromatic poly (ethyleneoxy) sulphates such as sulfates or condensation products of ethylene oxide and nonyl phenol. (usually having 1 to 6 oxyethylene groups per molecule). 7. CHROMOPHORE OR COLORING Complexed iodines offer the advantage of being chromophoric, that is, easily visible when applied to the teat. Other antimicrobial agents do not have this characteristic; therefore, the compositions of this invention may include a water-dispersible or water-soluble coloring agent (dyes or pigments) or mixtures of agents that render the chromophoric compositions, which have sharp contrast with the skin of the teat, which allows the administrator of the dairy cattle visually discern that the tits have been treated. 8. OTHER ADJUVANTS Alternatively, the compositions of the invention may comprise any number of optional ingredients, ie adjuvants. Depending on the benefits provided, the adjuvants can partially or completely displace the carrier in the composition. Generally according to the invention, form adjuvants that assist in the application of the invention with respect to physical and chemical stability, barrier film formation, maintenance of tits health, embodiment may be included within this composition. , physical form, manufacturing process and aesthetics. Of course these functions can be carried out exclusively by ingredients of the composition already described or mixtures thereof; however, there may be form or application or performance situations that require additional effect which can be accomplished by introducing an additional inorganic or organic agent or agents and mixtures thereof into the composition.

Form adjuvants include coupling agents, solubilizers, or hydrotropes used to maintain the physical integrity and storage stability of the present composition. For this purpose, any number of monofunctional or polyfunctional alcohols can be used. For compositions designated to provide a barrier film or prophylactic protection, adjuvants are included that form additional films which typically work in cooperation with thickeners, for example polyvinyl alcohol and latex polymers such as ethyl acrylate / methyl methacrylate copolymer . The compositions of the invention may optionally include medicaments, for example sunscreens such as para-aminobenzoic acid and curing agents such as allantoin to provide curative action and stimulation of new tissue formation; preservatives such as methylparaben, propylparaben, sorbic and benzoic acids or salts thereof to retard bacterial growth and prolong shelf life; antioxidants such as BHT (butylated hydroxytoluene), BHA (butylated hydroxyanisole), TBHQ (terbutilhidroquinona), or propilgalato to retard the oxidative or hydrolytic degradation; sequestering agents such as aminopolycetates, polyphosphonates, aminopolyphosphonates, polycarboxylates, and condensed phosphates; and, manufacturing processing agents, for example defoaming additives employed to facilitate grinding and mixing. A wide variety of ingredients useful in the treatment of mastitis control can be included in the composition herein. This list is not intended to be exhaustive and other optional ingredients, which may not be on the list but are well known in the art, may also be used in the composition. The examples are not intended to be limited in any way. In certain cases, some of the individual adjuvants may overlap other categories. The adjuvants used will be selected so as not to interfere with the antimicrobial action of the composition and to avoid physical or chemical instability of the product. Table 2, below, provides guidance for concentrations of constituents according to the invention.

TABLE 2 COMPOSITIONS OF TISSUE SEALER MIXTURE (Percent by weight) In use, the constituents of the tits sealer can be transported to the site of use in separate containers. For example, one container may comprise an antimicrobial and another container may contain an emollient. These two systems can be mixed at the point of use, with a carrier in a storage container. By mixing concentrates at the point of use, incompatibilities are avoided between, for example, regulatory and emollient systems Although not explicitly shown, it will be appreciated that the various components such as computer 100, pumps 16, 18 and 20, etc. are connected to Adequate power supplies and other peripheral components to operate in their expected manner. The above description of the preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form described. Many modifications and variations are possible in light of the previous teachings. It is intended that the approach of the invention not be limited by the approach of this detailed description, but by the claims appended hereto.

Claims (9)

1. A method for dosing a desired composition at the point of use, the method comprising the steps of: (a) transporting a plurality of concentrated chemical compositions to the point of use using a vehicle having a plurality of concentrate containers disposed therein , each concentrate container stores one of a plurality of concentrated chemical product compositions; (b) generating a formulation of a desired composition by specifying predetermined amounts of at least one of the concentrated chemical compositions; and (c) dosing the predetermined amounts of at least one of the concentrated chemical compositions to a storage container at the point of use.

2. The method of claim 1, wherein the formulation specifies that at least two of the concentrated chemical compositions are mixed. The method of claim 1, wherein the step of generating includes the step of selecting the desired formulation of the final composition from a plurality of previously determined formulations. The method of claim 1, wherein the step of generating includes the step of generating a formulation adapted to the client of the final composition. The method of claim 2, further comprising the step of determining an amount of the final composition required at the point of use, and wherein the step of generation includes the step of calculating the previously determined amounts of concentrated chemical compositions required to form the determined amount of the desired formulation of the final composition. The method of claim 6, further comprising the step of calculating the cost of the final composition brought to the point of use based on the amount of each concentrated chemical composition delivered to the storage container. 8. The method of claim 7, further comprising the step of generating an invoice with the calculated cost. The method of claim 2, wherein at least two of the concentrated chemical compositions are incompatible when in concentrated form. The method of claim 2, wherein the final composition is a titler sealant. The method of claim 2, wherein the step of generating comprises: receiving the entry designating a particular formulation; and accessing a formula database to recover the previously determined amounts of the concentrated chemical compositions associated with the formulation. 12. A dosing apparatus mounted on a vehicle for dosing a final composition at the point of use, the apparatus comprising: (a) a plurality of concentrate containers mounted on a delivery vehicle, each concentrated container accommodating a concentrated chemical composition for its use in the formulation of a final composition; (b) at least one delivery mechanism coupled in fluid communication with the plurality of concentrate containers to selectively deliver a measured amount of each concentrated chemical composition to a storage container at the point of use; and (c) a controller configured to activate the delivery mechanism to deliver a desired formulation of final composition having predetermined amounts of at least two of the concentrated chemical compositions. The apparatus of claim 12, wherein the delivery mechanism includes a plurality of fixed blow pumps, each of which is coupled to one of the plurality of concentrate containers; whereby the controller activates a pump for a predetermined period of time to deliver a predetermined amount of concentrated chemical composition. The apparatus of claim 13, wherein the delivery mechanism further comprises a plurality of filling peaks, each of which is coupled with one of a plurality of pumps. 15. The apparatus of claim 13, wherein the computer includes a plurality of previously determined formulations; whereby the desired formulation is selected from the plurality of previously determined formulations. 16. The apparatus of claim 13, wherein the computer is configured to generate a formulation adapted to the client, of the final composition. The apparatus of claim 13, wherein the computer is configured to receive as input an amount of the final composition to be administered, and to calculate therefrom the previously determined amounts of concentrated chemical compositions. The apparatus of claim 13, wherein the computer includes an invoice generation program configured to calculate the cost of the final composition administered at the point of use based on the amount of each concentrated chemical composition administered to the storage container, and generate an invoice from it. 19. A method for generating a formulation of a final composition for dosing into a storage container the desired formulation by specifying predetermined amounts of at least two concentrated chemical compositions, the method comprising: receiving input designating a particular formulation; receive entry designating the desired quantity of the formulation to be dosed; producing commands for a controller designating the quantity of each of the at least two concentrated chemical compositions to be dosed; and produce a command for the controller to begin dosing operations. The method of claim 19 further comprising generating a report containing information about the formulation and amount of the dosage formulation.